logo-loader
Cannabics Pharmaceuticals

Cannabics Pharmaceuticals opens up new lab and prepares to accept fresh biopsies

Cannabics Pharmaceuticals Inc (OTCQB:CNBX) CEO Eyal Barad joined Proactive Investors' Steve Darling at the 9th Annual LD Micro Invitational Investor Conference in Los Angeles, CA. The biotechnology company develops pharmaceuticals focusing on cancer research and focuses on the development of therapies and tools aimed at diverse ailments.

Quick facts: Cannabics Pharmaceuticals

Price: $0.26

Market: OTCQB
Market Cap: $34.96 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

hVIVO PLC's 2020 pipeline 'looking strong' as it expands service offerings

hVIVO PLC's (LON:HVO) executive chairman Trevor Phillips tells Proactive London's Andrew Scott the business is now better positioned to be profitable next year. The creator of pioneering human disease models based upon viral challenge generated revenues of £5.9mln in the six months ended June...

9 hours, 43 minutes ago

2 min read

;